Atlas Trials

Study of Combination POM, BTZ, Low-Dose DEX, and DARA (PVD-DARA) in Patients With RRMM

Clinical trial NCT05408026 · WITHDRAWN

Trial details

NCT number
NCT05408026
Sponsor
Alliance Foundation Trials, LLC.
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Relapsed or Refractory Multiple Myeloma
Start date
2022-10-01
Primary completion
2025-10-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.